Skip to content
10-Q

Quarterly Report

Astria Therapeutics, Inc.

0001410578-25-001698

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 56.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 56.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 54.39M sh
Capex Q2 2025 · Jun 30, 2025 $590K
Capex Q2 2025 · Jun 30, 2024 $305K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$70.08M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$35.89M
Short Term Investments Q2 2025 · Jun 30, 2025 $182.86M
Short Term Investments Q2 2025 · Dec 31, 2024 $268.31M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $76.32M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $59.82M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $87.21M
Stockholders Equity Q2 2025 · Jun 30, 2025 $260.51M
Stockholders Equity Q2 2025 · Mar 31, 2025 $289.29M
Stockholders Equity Q2 2025 · Dec 31, 2024 $319.26M
Stockholders Equity Q2 2025 · Jun 30, 2024 $347.08M
Stockholders Equity Q2 2025 · Mar 31, 2024 $367.74M
Stockholders Equity Q2 2025 · Dec 31, 2023 $243.12M
Current Liabilities Q2 2025 · Jun 30, 2025 $18.04M
Current Liabilities Q2 2025 · Dec 31, 2024 $19.13M
Total Liabilities Q2 2025 · Jun 30, 2025 $21.41M
Total Liabilities Q2 2025 · Dec 31, 2024 $23.1M
Current Assets Q2 2025 · Jun 30, 2025 $268.59M
Current Assets Q2 2025 · Dec 31, 2024 $334.64M
Total Assets Q2 2025 · Jun 30, 2025 $281.92M
Total Assets Q2 2025 · Dec 31, 2024 $342.36M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.15
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.43
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.81
Eps Basic Q2 2025 · Jun 30, 2025 −$0.57
Eps Basic Q2 2025 · Jun 30, 2025 −$1.15
Eps Basic Q2 2025 · Jun 30, 2024 −$0.43
Eps Basic Q2 2025 · Jun 30, 2024 −$0.81
Sga Expense Q2 2025 · Jun 30, 2025 $9.88M
Sga Expense Q2 2025 · Jun 30, 2025 $19.08M
Sga Expense Q2 2025 · Jun 30, 2024 $8.09M
Sga Expense Q2 2025 · Jun 30, 2024 $16.52M
Net Income Q2 2025 · Jun 30, 2025 −$33.05M
Net Income Q2 2025 · Jun 30, 2025 −$66.76M
Net Income Q2 2025 · Mar 31, 2025 −$33.71M
Net Income Q2 2025 · Jun 30, 2024 −$24.17M
Net Income Q2 2025 · Jun 30, 2024 −$44.1M
Net Income Q2 2025 · Mar 31, 2024 −$19.93M
Operating Income Q2 2025 · Jun 30, 2025 −$35.82M
Operating Income Q2 2025 · Jun 30, 2025 −$72.82M
Operating Income Q2 2025 · Jun 30, 2024 −$28.8M
Operating Income Q2 2025 · Jun 30, 2024 −$52.95M